AXA S.A. announces filing of amendment No. 2 to AXA US registration statement for Initial Public Offering
AXA S.A. (“AXA”) today announced the filing by AXA Equitable Holdings, Inc. (“AEH”), AXA’s wholly-owned U.S. holding company, of Amendment No. 2 to the registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering (“IPO”) and U.S. listing of AEH common stock. The offering is expected to consist of a minority stake in AEH’s common stock, to be sold by AXA as selling stockholder. AXA anticipates that the IPO will occur in the second quarter of 2018. There can be no assurance that the IPO will be completed on the expected timeline or at all.
The shares will be offered by a group of underwriters led by Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, with Barclays Capital Inc. and Citigroup Global Markets Inc. also acting as underwriters for the offering. The number of shares to be offered and the price range for the proposed offering have not yet been determined.
A registration statement relating to the proposed IPO has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.